RxDoctor Payments Data

Norman Regal, DPM

Podiatrist · Greensboro, NCNPI 1831294560

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.5% of the total across 79 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 13.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $935, 6.4 times the $147 reported in 2019.

$3,300in general payments, 2019–2025

Across 79 payments — averaging $41.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Treace Medical Concepts, Inc.$459
  • Amgen$394
  • Kerecis Limited$301
  • Convatec Inc.$293
  • Smith+Nephew$266
  • Averitas Pharma Inc.$236
  • plus $1K from 23 others

What the payments were for

  • Food & beverage$3,28299%
  • Entertainment$181%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,300 in reported general payments places this provider in the 65th percentile of 109 podiatrist providers in North Carolina.

See all podiatrist providers in North Carolina

Medicare billing

Part B allowed, 2024
$75,215
Medicare patients
427
Services billed
1,390

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin110$1,241
Doxycycline Hyclate74$827
Diclofenac Sodium77$579
Nitroglycerin PatchNitroglycerin15$512
Terbinafine Hcl23$323
Allopurinol35$206
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen42$203
Methylprednisolone13$84
Meloxicam16$81

Paid to pharmacies, not to this prescriber.

Other podiatrist in Greensboro

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →